Publications for Wilbert S. Aronow wilbert_aronow@nymc.edu

NYMC School of Medicine
  • Patel, K., Fonarow, G. C., Ahmed, M., Morgan, C., Aronow, W. S., Anker, S. D., . . . Ahmed, A. (2014). Calcium channel blockers and outcomes in older patients with heart failure and preserved ejection fraction. Circulation: Heart Failure, 7(6), 945-952. doi:10.1161/CIRCHEARTFAILURE.114.001301

  • Phatak, P., Khanagavi, J., Aronow, W. S., Puri, S., Yusuf, Y., & Puccio, C. (2014). Pericardial synovial sarcoma: Challenges in diagnosis and management. F1000research, 3, 15. doi:10.12688/f1000research.3-15.v2

  • Pierre-Louis, B., Guddati, A. K., Syed, M. K. H., Gorospe, V. E., Manguerra, M., Bagchi, C., . . . Aronow, W. (2014). Exercise capacity as an independent risk factor for adverse cardiovascular outcomes among nondiabetic and diabetic patients. Archives of Medical Science: AMS, 10(1), 25-32. doi:10.5114/aoms.2014.40731

  • Sardar, P., Chatterjee, S., Herzog, E., Pekler, G., Mushiyev, S., Visco, F., . . . Aronow, W. S. (2014). New oral anticoagulants in patients with cancer: Current state of evidence. American Journal of Therapeutics, doi:10.1097/MJT.0000000000000055

  • Sardar, P., Nairooz, R., Chatterjee, S., Wetterslev, J., Ghosh, J., & Aronow, W. S. (2014). Meta-analysis of risk of stroke or transient ischemic attack with dabigatran for atrial fibrillation ablation. The American Journal of Cardiology, 113(7), 1173-1177. doi:10.1016/j.amjcard.2013.12.027

  • Sharma, M., Pinnamaneni, S., Aronow, W. S., Jozwik, B., & Frishman, W. H. (2014). Existing drugs and agents under investigation for pulmonary arterial hypertension. Cardiology in Review, 22(6), 297-305. doi:10.1097/CRD.0000000000000035

  • Sinha, N., Devabhaktuni, S., Kadambi, A., McClung, J. A., Aronow, W. S., & Lehrman, S. G. (2014). Can echocardiographically estimated pulmonary arterial elastance be a non-invasive predictor of pulmonary vascular resistance? Archives of Medical Science: AMS, 10(4), 692-700. doi:10.5114/aoms.2014.44860

  • White, M., Patel, K., Caldentey, G., Deedwania, P., Kheirbek, R., Fletcher, R. D., . . . Aronow, W. S. (2014). Racial differences in mortality in patients with advanced systolic heart failure: Potential role of right ventricular ejection fraction. International Journal of Cardiology, 177(1), 255-260. doi:10.1016/j.ijcard.2014.09.094

  • Ahmed, A., Rich, M. W., Zile, M., Sanders, P. W., Patel, K., Zhang, Y., . . . Aronow, W. S. (2013). Renin-angiotensin inhibition in diastolic heart failure and chronic kidney disease. American Journal of Medicine, 126(2), 150-161. doi:10.1016/j.amjmed.2012.06.031

  • Alagiakrishnan, K., Banach, M., Jones, L. G., Ahmed, A., & Aronow, W. S. (2013). Medication management of chronic heart failure in older adults. Drugs & Aging, 30(10), 765-782. doi:10.1007/s40266-013-0105-9

  • Alagiakrishnan, K., Banach, M., Jones, L. G., Datta, S., Ahmed, A., & Aronow, W. S. (2013). Update on diastolic heart failure or heart failure with preserved ejection fraction in the older adults. Annals of Medicine, 45(1), 37-50. doi:10.3109/07853890.2012.660493

  • Aronow, W. S. (2013). A review of the pathophysiology, diagnosis, and treatment of aortic valve stenosis in elderly patients. Hospital Practice, 41(4), 66-77. doi:10.3810/hp.2013.10.1082

  • Aronow, W. S. (2013). Antiplatelet drug use in patients with non-ST-segment elevation acute coronary syndromes. Postgraduate Medicine, 125(1), 51-58. doi:10.3810/pgm.2013.01.2624

  • Aronow, W. S. (2013). Aortic valve disease in the elderly. In W. S. Aronow, J. L. Fleg, & M. W. Rich (Eds.), Tresch and Aronow's cardiovascular disease in the elderly (5th ed., pp. 348-375). Boca Raton, FL: CRC Press.

  • Aronow, W. S. (2013). Diabetic cardiomyopathy in the elderly. Current Cardiovascular Risk Reports, 7(6), 490-494. doi:10.1007/s12170-013-0351-8

  • Aronow, W. S. (2013). Editorial on hemoglobin A1c, blood pressure, and low-density lipoprotein cholesterol goals in diabetics. World Journal of Cardiology, 5(5), 119-123. doi:10.4330/wjc.v5.i5.119

  • Aronow, W. S. (2013). Editorial on treatment of dyslipidemia in patients with diabetes mellitus. Cardiovascular Pharmacology: Open Access, 2(3) [Article e111]. This material can be found here.

  • Aronow, W.S. (2013). Hemoglobin A1c, blood pressure, and serum low-density lipoprotein cholesterol goals in diabetics. Journal of Clinical & Experimental Cardiology, 4(3) [Article e122]. doi:10.4172/2155-9880.1000e122

  • Aronow, W. S. (2013). Hypertension: How to treat the elderly. Consultant360, 53(9). This material can be found here.

  • Aronow, W. S. (2013). Hypertension-related stroke prevention in the elderly. Current Hypertension Reports, 15(6), 582-589. doi:10.1007/s11906-013-0384-x

  • Aronow, W. S. (2013). Indications for surgical aortic valve replacement. Journal of Cardiovascular Diseases & Diagnosis, 1(4) [Article e103]. doi:10.4172/2329-9517.1000e103

  • Aronow, W. S. (2013). Ischaemic heart disease. In D. J. Stott & G. D. O. Lowe (Eds.), Cardiovascular disease and health in the older patient: Expanded from 'Pathy's principles and practice of geriatric medicine' (pp. 152-171). Chichester, England: Wiley-Blackwell.

  • Aronow, W. S. (2013). Management of mitral stenosis. Journal of Cardiovascular Diseases & Diagnosis, 1(5) [Article e104]. doi:10.4172/2329-9517.1000e104

  • Aronow, W. S. (2013). Management of peripheral artery disease in the elderly. In W. S. Aronow, J. L. Fleg, & M. W. Rich (Eds.), Tresch and Aronow's cardiovascular disease in the elderly (5th ed., pp. 694-714). Boca Raton, FL: CRC Press.

  • Aronow, W. S. (2013). Management of the older patient after acute myocardial infarction. In W. S. Aronow, J. L. Fleg, & M. W. Rich (Eds.), Tresch and Aronow's cardiovascular disease in the elderly (5th ed., pp. 272-295). Boca Raton, FL: CRC Press.

First Prev 3 4 5 6 7 8 9 10 11 12 Next Last